Cleared Traditional

FT4 METHOD FOR THE DIMENSION RXL CLINICAL CHEMISTRY SYSTEM

K971141 · Dade Chemistry Systems, Inc. · Chemistry
Apr 1997
Decision
31d
Days
Class 2
Risk

About This 510(k) Submission

K971141 is an FDA 510(k) clearance for the FT4 METHOD FOR THE DIMENSION RXL CLINICAL CHEMISTRY SYSTEM, a Radioimmunoassay, Free Thyroxine (Class II — Special Controls, product code CEC), submitted by Dade Chemistry Systems, Inc. (Newark, US). The FDA issued a Cleared decision on April 28, 1997, 31 days after receiving the submission on March 28, 1997. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1695.

Submission Details

510(k) Number K971141 FDA.gov
FDA Decision Cleared SESE
Date Received March 28, 1997
Decision Date April 28, 1997
Days to Decision 31 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code CEC — Radioimmunoassay, Free Thyroxine
Device Class Class II — Special Controls
CFR Regulation 21 CFR 862.1695